세계의 바큐로바이러스 발현 시스템 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별

Baculovirus Expression System Market is estimated to be valued at USD 436.0 Mn in 2025 and is expected to reach USD 781.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

A baculovirus expression system is a highly versatile and widely utilized tool in biotechnology for the production of recombinant proteins. Baculovirus is an insect virus that infects insect cells, and they have been engineered to express foreign genes of interest. This system offers several advantages over other expression systems including high protein yields, post-translational modifications, and scalability.

The baculovirus expression system has found applications in various fields such as biopharmaceutical production, protein research, vaccine development, and gene therapy. The system has been extensively studied and optimized over the years, leading to improved efficiency and versatility.

Market Dynamics:

The global baculovirus expression system market is expected to witness significant growth in the coming years. Several factors are driving this growth, including the increasing demand for recombinant proteins for therapeutic and research purposes. The system's ability to produce high levels of complex and functional proteins has made it a preferred choice in the biopharmaceutical industry.

Another driver of the market is the rising investments in research and development activities for the development of novel therapies and vaccines. The baculovirus expression system provides a reliable and cost-effective platform for the production of these biologics.

However, the market also faces certain restraints. One of the major challenges is the complex and time-consuming process of protein production using the baculovirus expression system. The optimization and scaling-up of the system requires technical expertise and can be labor-intensive.

Nevertheless, the market presents numerous opportunities for growth. The increasing focus on personalized medicine and the development of advanced therapeutics creates a demand for customized protein production systems. The baculovirus expression system, with its flexibility and ability to produce a wide range of proteins, is well-positioned to meet this demand.

Key Features of the Study:

• This report provides an in-depth analysis of the global baculovirus expression system market including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key players in the global baculovirus expression system market are profiled including company highlights, product portfolios, key highlights, financial performance, and strategies
• The key companies covered in this study include Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, and Virovek
• Insights from this report would enable marketers and management authorities to make informed decisions regarding future product launches, technology upgrades, market expansion, and marketing tactics
• The global baculovirus expression system market report caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would benefit from the strategy matrices used in analyzing the global baculovirus expression system market, making decision-making easier

Global Baculovirus Expression System Market Segmentation:

• By Product Type
  • Baculovirus
  • Expression Vector
  • Reagents
  • Others
• By Application
  • Therapeutics
  • Vaccines
  • Protein Purification
  • Others
• By End User
  • Biopharmaceutical Companies
  • Research Institutes
  • Others
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • Thermo Fisher Scientific
  • Merck KGaA
  • Takara Bio
  • Agilent Technologies
  • Oxford Expression Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories
  • New England Biolabs
  • Genscript Biotech Corporation
  • Syngene International Limited
  • Sartorius AG
  • Aragen Bioscience
  • Vivopure
  • Creative Biogene
  • Absolute Antibody
  • Rockland Immunochemicals
  • Protein Technologies, Inc. (PTI)
  • Proteogenix
  • Virovek

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Baculovirus Expression System Market, By Product Type
  • Global Baculovirus Expression System Market, By Application
  • Global Baculovirus Expression System Market , By End User
  • Global Baculovirus Expression System Market , By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• The increasing demand for recombinant proteins for therapeutic and research purposes
  • Restraints
• The complex and time-consuming process of protein production
  • Opportunities
• The increasing focus on personalized medicine and the development of advanced therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Baculovirus Expression System Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Baculovirus Expression System Market, By Product Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Baculovirus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Expression Vector
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Baculovirus Expression System Market, By Application, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Protein Purification
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Baculovirus Expression System Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Baculovirus Expression System Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 -2032,(US$ Mn)
    • U.S
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • U.K
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 -2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2020 - 2032, (US$ Mn)
    • GCC
    • IsraelNorth Africa
    • Central Africa
    • South Africa
    • Rest of Middle East & Africa

9. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Takara Bio
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Oxford Expression Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Promega Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Qiagen N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• New England Biolabs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Genscript Biotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Syngene International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sartorius AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Aragen Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vivopure
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Biogene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Absolute Antibody
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Rockland Immunochemicals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Protein Technologies, Inc. (PTI)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Proteogenix
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virovek
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us